ESG Report 2024

29 Environmental, Social and Governance Report 2024 The United Laboratories International Holdings Limited Serving overseas customers 400+ Total number of countries covered by overseas exports nearly 80 Total number of products exported overseas in the Year 30 New customers developed in the overseas market in the Year 74 Business Progress in the Global Market Additionally, during the Year, the Group secured a tender from the Brazilian Ministry of Health for human insulin injection procurement, marking a pivotal milestone in the internationalization of our finished products. Moving forward, we will prioritize diabetes-focused products and strategically advance the global deployment of human-use finished products, with particular emphasis on countries and regions along the Belt and Road Initiative routes. Improving Medical Affordabiliity 6.3 6.3.1 Selected in National Medical Insurance Drug List and National Essential Drug List The National Healthcare Security Administration ( 國家醫療保障局) announced the “National Basic Medical Insurance Drug List (2024 edition)” (NMIDL) would be officially implemented on January 1, 2025. During the reporting period, the Group has 67 products included in the NMIDL, with 24 Category A products and 43 Category B products. In addition, the Group also has 31 products in the “National Essential Drug List ” (NEDL) . (2018 edition) At the same time, the Group actively plans and promotes licensing-out and cooperation, and continues to deepen its global strategic layout. The Group is committed to providing more comprehensive treatment options and medication choices for patients around the world, and making positive contributions to improving medical accessibility.